CVSI - CV Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

CV Sciences, Inc.

2688 South Rainbow Boulevard
Suite B
Las Vegas, NV 89146
United States
866-290-2157
http://www.cvsciences.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees78

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph D. DowlingCEO, Sec. & Director600.6kN/A1957
Mr. Michael J. Mona IIICo-Founder, COO & Director548.39kN/A1986
Mr. Joerg GrasserChief Financial Officer3.43kN/AN/A
Dr. Joseph Maroon F.A.C.S., M.D.MD & Director35kN/A1941
Dr. Douglas MacKay NDSr. VP of Scientific & Regulatory AffairsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CV Sciences, Inc. operates as a life science company. It operates through two segments, Consumer Products and Specialty Pharmaceuticals. The Consumer Products segment manufactures, markets, and sells consumer products containing hemp-based cannabidiol oil under the PlusCBD brand in various market sectors, including nutraceutical, beauty care, specialty foods, and vape. This segment provides its hemp extract products in balms, sprays, drops, capsules, gummies, and softgel forms. It also sells raw materials to various customers that produce products for resale into the market in Europe. The Specialty Pharmaceuticals segment develops cannabinoids to treat a range of medical indications. Its product candidate is CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was founded in 2010 and is based in Las Vegas, Nevada.

Corporate Governance

CV Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.